Corporate News 16-Feb-23
USFDA issues EIR for Piramal Pharma's Lexington facility
Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing facility located at Lexington (Kentucky, USA) and the inspection has now been successfully closed by the USFDA.
Previous News
Piramal Pharma consolidated net profit declines 63.60% in the December 2024 quarter
( Results - Announcements 29-Jan-25 07:39 )
Piramal Pharma Ltd spurts 1.31%, gains for third straight session
( Hot Pursuit - 27-Mar-26 13:05 )
Piramal Pharma to discuss results
( Corporate News - 14-Jan-25 14:25 )
Piramal Pharma fixes record date for rights issue
( Market Beat - Reports 29-Jul-23 13:09 )
Piramal Pharma’s Lexington facility receives four USFDA observations
( Hot Pursuit - 12-Dec-25 12:24 )
Piramal Pharma to conduct AGM
( Corporate News - 14-Jun-25 14:54 )
Piramal Pharma announces cessation of director
( Corporate News - 05-Feb-26 11:44 )
Piramal Pharma to announce Quarterly Result
( Corporate News - 19-Jul-25 09:22 )
Piramal Pharma’s Canada facility gets zero USFDA observation
( Hot Pursuit - 02-Jun-25 11:16 )
Broader mrkt outperforms; PSU bank shares in demand
( Market Commentary - Mid-Session 24-Oct-24 10:34 )
Piramal Pharma receives SBTi validation for its GHG commitment
( Corporate News - 17-Sep-24 10:14 )
Other Stories
Bharat Coking Coal to conduct board meeting
11-Apr-26 17:05
RS Software (India) to conduct board meeting
11-Apr-26 17:05
Garden Reach Shipbuilders& Engineers to discuss results
11-Apr-26 17:05
Aesthetik Engineers to hold EGM
11-Apr-26 16:55
Anzen India Energy Yield Plus Trust to convene board meeting
11-Apr-26 16:55
Pennar Industries schedules EGM
11-Apr-26 16:55
Almondz Global Securities to conduct EGM
11-Apr-26 16:55
Confidence Petroleum India schedules EGM
11-Apr-26 16:54
India Infraspace to convene EGM
11-Apr-26 16:54
Religare Enterprises schedules EGM
11-Apr-26 16:54
Back
Top
